Log in to save to my catalogue

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9156412

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

About this item

Full title

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

Publisher

London: Nature Publishing Group UK

Journal title

Nature materials, 2022-06, Vol.21 (6), p.710-720

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Activation of the innate immune STimulator of INterferon Genes (STING) pathway potentiates antitumour immunity, but systemic delivery of STING agonists to tumours is challenging. We conjugated STING-activating cyclic dinucleotides (CDNs) to PEGylated lipids (CDN-PEG-lipids; PEG, polyethylene glycol) via a cleavable linker and incorporated them into...

Alternative Titles

Full title

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9156412

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9156412

Other Identifiers

ISSN

1476-1122

E-ISSN

1476-4660

DOI

10.1038/s41563-022-01251-z

How to access this item